Chemed SG&A Expenses 2010-2024 | CHE

Chemed annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Chemed sg&a expenses for the quarter ending June 30, 2024 were $0.102B, a 7.65% increase year-over-year.
  • Chemed sg&a expenses for the twelve months ending June 30, 2024 were $0.418B, a 11.21% increase year-over-year.
  • Chemed annual sg&a expenses for 2023 were $0.395B, a 10.15% increase from 2022.
  • Chemed annual sg&a expenses for 2022 were $0.359B, a 2.18% decline from 2021.
  • Chemed annual sg&a expenses for 2021 were $0.367B, a 11.06% increase from 2020.
Chemed Annual SG&A Expenses
(Millions of US $)
2023 $395
2022 $359
2021 $367
2020 $330
2019 $306
2018 $271
2017 $277
2016 $244
2015 $238
2014 $223
2013 $216
2012 $209
2011 $202
2010 $202
2009 $197
Chemed Quarterly SG&A Expenses
(Millions of US $)
2024-06-30 $102
2024-03-31 $116
2023-12-31 $100
2023-09-30 $100
2023-06-30 $95
2023-03-31 $100
2022-12-31 $97
2022-09-30 $84
2022-06-30 $88
2022-03-31 $90
2021-12-31 $92
2021-09-30 $89
2021-06-30 $94
2021-03-31 $92
2020-12-31 $87
2020-09-30 $88
2020-06-30 $85
2020-03-31 $71
2019-12-31 $83
2019-09-30 $77
2019-06-30 $72
2019-03-31 $74
2018-12-31 $67
2018-09-30 $67
2018-06-30 $68
2018-03-31 $69
2017-12-31 $72
2017-09-30 $67
2017-06-30 $69
2017-03-31 $69
2016-12-31 $63
2016-09-30 $59
2016-06-30 $63
2016-03-31 $59
2015-12-31 $65
2015-09-30 $56
2015-06-30 $58
2015-03-31 $59
2014-12-31 $60
2014-09-30 $54
2014-06-30 $54
2014-03-31 $56
2013-12-31 $58
2013-09-30 $49
2013-06-30 $53
2013-03-31 $56
2012-12-31 $53
2012-09-30 $53
2012-06-30 $50
2012-03-31 $53
2011-12-31 $49
2011-09-30 $48
2011-06-30 $50
2011-03-31 $56
2010-12-31 $55
2010-09-30 $48
2010-06-30 $50
2010-03-31 $49
2009-12-31 $54
2009-09-30 $48
2009-06-30 $50
2009-03-31 $46
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.694B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.379B 12.93
Quest Diagnostics (DGX) United States $17.308B 17.75
DaVita (DVA) United States $13.689B 16.84
Encompass Health (EHC) United States $9.303B 22.88
Elanco Animal Health (ELAN) United States $7.242B 16.28
Option Care Health (OPCH) United States $5.321B 26.14
RadNet (RDNT) United States $4.963B 117.74
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
U.S Physical Therapy (USPH) United States $1.274B 34.50
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00